Methods and compositions for treating and inhibiting retinal neovascularization
US7141607B1 · kind B1 · utility
6Cited by
37References
43Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 10, 2000 |
| Grant date | Nov 28, 2006 |
| Priority date | — |
| Expiry date | Mar 10, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions for the prophylactic and therapeutic treatment of retinal disorders associated with neovascularization using topical ophthalmic compositions comprising hydroxamic acid matrix metalloproteinase inhibitors such as batimastat.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.